학술논문
LATIFY: Phase 3 study of ceralasertib plus durvalumab vs docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer that progressed on or after anti-PD-(L) 1 and platinum-based therapy.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755